migraine treatment
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
Japan’s Shin Nippon Biomedical Labs to buy US-based Satsuma for nasal powder migraine drug
Developed by Satsuma, STS101 is a nasal powder formulation of the anti-migraine drug, dihydroergotamine mesylate.
Drug approvals boost Japanese migraine treatment online
Some players have been highly active in digital channels of various countries.
Resource Center
Read Here
Advertise
Sign Up
Event News
Only one of two leading firms achieves 80% of their digital transformation project targets.
